Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07761455
Prophylactic IABP in Delayed-Presentation Anterior STEMIQilu Hospital of Shandong UniversityNot Yet RecruitingNot Applicable
NCT07761455Not Yet Recruiting
Not Applicable
Prophylactic IABP in Delayed-Presentation Anterior STEMIQilu Hospital of Shandong...
NCT07759973
Neurocomputational Dynamics of CooperationEmory UniversityNot Yet RecruitingNot Applicable
NCT07759973Not Yet Recruiting
Not Applicable
Neurocomputational Dynamics of CooperationEmory University
NCT07761130
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke (iHeLP)Health Research Board, IrelandCompletedNot Applicable
NCT07761130Completed
Not Applicable
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke...Health Research Board, Ir...
NCT07761429
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)Shandong New Time Pharmaceutical Co., LTDRecruitingPhase 2
NCT07761429Recruiting
Phase 2
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Tr...Shandong New Time Pharmac...
NCT07761325
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic ChemotherapySun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 3
NCT07761325Not Yet Recruiting
Phase 3
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone...Sun Yat-Sen Memorial Hosp...
NCT07761286
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular CarcinomaCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 1
NCT07761286Not Yet Recruiting
Phase 1
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection f...CSPC Megalith Biopharmace...
NCT07760519
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLCAstraZenecaNot Yet Recruiting
NCT07760519Not Yet Recruiting
—
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adul...AstraZeneca
NCT07759440
Clinical Outcomes of Transconjunctival Vs Transcutaneous Approaches in Orbital Fracture RepairAlexandria UniversityRecruitingNot Applicable
NCT07759440Recruiting
Not Applicable
Clinical Outcomes of Transconjunctival Vs Transcutaneous Approaches in Orbital F...Alexandria University
NCT07761559
Effect of a Nutrition Education Intervention on Ultra-Processed Food Awareness and Consumption Among University StudentsBENGİSU KARAGÖZActive Not RecruitingNot Applicable
NCT07761559Active Not Recruiting
Not Applicable
Effect of a Nutrition Education Intervention on Ultra-Processed Food Awareness a...BENGİSU KARAGÖZ
NCT07761065
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion in Skeletal Open Bite CasesAin Shams UniversityCompletedNot Applicable
NCT07761065Completed
Not Applicable
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion...Ain Shams University
NCT07759531
This Study Aims to Evaluate the Cultural Adaptation, Implementation, and Effectiveness of the RAISE Program Grounded in Malti's 3 E's Model and the Kindness Developmental Paradigm in PortugalCâmara Municipal OeirasNot Yet RecruitingNot Applicable
NCT07759531Not Yet Recruiting
Not Applicable
This Study Aims to Evaluate the Cultural Adaptation, Implementation, and Effecti...Câmara Municipal Oeiras
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07759362
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)Endo USA Inc., a Keenova Therapeutics CompanyNot Yet RecruitingPhase 3
NCT07759362Not Yet Recruiting
Phase 3
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT...Endo USA Inc., a Keenova...
NCT07760532
Comparing Facial Aging Between Identical Twins With 3D ImagingPonsky Facial Aesthetics And Plastic Surgery, LlcNot Yet Recruiting
NCT07760532Not Yet Recruiting
—
Comparing Facial Aging Between Identical Twins With 3D ImagingPonsky Facial Aesthetics...
NCT07761247
Dual-Task Neuromuscular Warm-Up Exercises in Chronic Low Back PainIstinye UniversityNot Yet RecruitingNot Applicable
NCT07761247Not Yet Recruiting
Not Applicable
Dual-Task Neuromuscular Warm-Up Exercises in Chronic Low Back PainIstinye University
NCT07761728
The FLARE (Flurpiridaz vs. Rubidium Evaluation) TrialUniversity of California, Los AngelesRecruiting
NCT07761728Recruiting
—
The FLARE (Flurpiridaz vs. Rubidium Evaluation) TrialUniversity of California,...
NCT07761104
Phenotyping Acute Non-Severe Anemia in the Emergency DepartmentHospices Civils de LyonNot Yet RecruitingNot Applicable
NCT07761104Not Yet Recruiting
Not Applicable
Phenotyping Acute Non-Severe Anemia in the Emergency DepartmentHospices Civils de Lyon
NCT07760155
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus ErythematosusShanghai Escugen Biotechnology Co., LtdNot Yet RecruitingPhase 2
NCT07760155Not Yet Recruiting
Phase 2
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibod...Shanghai Escugen Biotechn...
NCT07761650
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital LahoreCompletedNot Applicable
NCT07761650Completed
Not Applicable
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital Lahore
NCT07759414
Chrono-Fasting in Overweight and Obese AdolescentsUniversity of ThessalyNot Yet RecruitingNot Applicable
NCT07759414Not Yet Recruiting
Not Applicable
Chrono-Fasting in Overweight and Obese AdolescentsUniversity of Thessaly
Result Breakdown
Not yet recruiting13 (65%)
Completed3 (15%)
Recruiting3 (15%)
Active, not recruiting1 (5%)
not_applicable12 (60%)
Not Specified3 (15%)
Phase 22 (10%)
Phase 32 (10%)
Phase 11 (5%)